A definition for influenza pandemics based on historial records

Journal of Infection

Volumn 63, Issue 4, 2011, Pages 252-259

  Potter, Chris W ^a   Jennings, Roy ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Definition of pandemic; Haemagglutinin; History of influenza; Influenza; Pandemics

Indexed keywords

INFLUENZA VIRUS HEMAGGLUTININ;

ARTICLE; CROSS REACTION; DISEASE CLASSIFICATION; DISEASE TRANSMISSION; EPIDEMIC; HEMAGGLUTINATION INHIBITION TEST; HIGH RISK POPULATION; HUMAN; INFLUENZA VIRUS A; MEDICAL LITERATURE; MORTALITY; NOMENCLATURE; NONHUMAN; PANDEMIC INFLUENZA; PUBLIC HEALTH; PUBLICATION; TREND STUDY; VIRUS IMMUNITY; VIRUS MUTATION; VIRUS STRAIN;

HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; INFLUENZA, HUMAN; ORTHOMYXOVIRIDAE; PANDEMICS; TERMINOLOGY AS TOPIC;

EID: 80052936238     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2011.04.013     Document Type: Article

References (67)

1. Hirsch A. Handbook of geographical and historical pathology 1883, New Sydenham Society, London.
2. Patterson K.D. A study in historical epidemiology 1987, Rowan and Littlefield, New Jersey.
3. Beveridge W.I.B. The chronicle of influenza epidemics. Hist Phylo Life Sci 1991, 223-235.
4. Webster R.G., Laver W.G. The influenza viruses and influenza antigenic variation in influenza viruses 1975, 260-314. Academic Press, New York. E.G. Kilbourne (Ed.).
5. Potter C.W. Chronicle of influenza pandemics. The influenza viruses and influenza 1998, 3-18. Blackwell Science Ltd, Oxford. K.G. Nicolson, R.G. Webster, A.J. Hay (Eds.).
6. Collier R. Revised WHO pandemic scale requires higher incidence of disease for most alert levels. Can Med Ass J 2009, 180(12):E95-E96.
7. Simonsen L., Clarke M.J., Schonberger L.B., Arden N.H., Cox N.J., Fukuda K. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Inf Dis 1998, 178:53-60.
8. Simonsen L., Olson D.R., Viboud C. Pandemic influenza and mortality: past evidence and projections for the future. the threat of pandemic influenza and mortality: are we ready? 2005, 89-114. DC Nt Ass Press. S.L. Mack, A. Mahmoud, S.M. Lemon (Eds.).
9. Miller M.A., Viboud C., Balinska M., Simonsen L. The signature features of influenza pandemics - implications for policy. New Eng J Med 2009, 360:2595-2598.
10. Morens D.M., Taubenberger J.K. Understanding influenza backward. JAMA 2009, 302:679-680.
11. Morens D.M., Taubenberger J.K., Fauci A.S. The persistent legacy of the 1918 influenza virus. New Eng J Med 2009, 361:225-229.
12. Hampson A.W. Influenza virus antigens and antigenic drift. Influenza 2002, 49-85. Elsevier, Amsterdam. C.W. Potter (Ed.).
13. Cox N.J., Subbarao K. Global epidemiology of influenza: past and present. Annu Revs Med 2000, 51:407-421.
14. Lui K.-J., Kendal A.P. Impact of influenza epidemics on mortality in the United States from October 1972 to may 1985. Amer J Pub Hlth 1987, 77:712-716.
15. Law R. There was also no new subtype. BMJ 2010, 340. c3460.
16. Cohen D., Carter P. WHO and the pandemic flu 'conspiracies'. Brit Med.J 2010, 340:2912.
17. Valleron A.-J., Cori A., Valtat S., Meurisse S., Carrat F., Boelle P.-Y. Transmissibility and geographic spread of the 1889 influenza pandemic. PNAS 2010, 107:8778-8781.
18. Parsons H.F. Fortner report and papers on epidemic influenza, 1889-92 1893, Local Government Board, London. S. Eyre (Ed.).
19. McHardy A.C., Adams B. The role of genomics in tracking the evolution of influenza A virus. PLoS Pathogens 2009, 5(10):e1000566.
20. Potter C.W., Oxford J.S. Determinants of immunity to influenza infection in man. Brit Med.J 1979, 35:69-75.
21. Hilleman M.R. Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control. Vaccine 2002, 3068-3087.
22. Smith W., Andrews C.H., Laidlaw P.P. A virus obtained from influenza patients. Lancet 1933, 2:66-68.
23. Schild G.C., Stuart-Harris C.H. Serology epidemiological studies with influenza A viruses. J Hyg (Camb) 1965, 63:479-490.
24. Taubenberger J.K., Reid A.H., Krafft A.E., Bijwaard K.E., Fanning T.G. Initial genetic characterisation of the 1918 " Spanish" influenza virus. Science 1997, 275:1793-1796.
25. Mulder J., Masurel N. Pre-epidemic antibody against the 1957 strain of Asiatic influenza in serum of older persons living in the Netherlands. Lancet 1958, 1:810-814.
26. Marine W.M., Workman W.H. Hong Kong influenza immunologic recapitulation. Amer J Epidem 1969, 90(6):406-415.
27. Taubenberger J.K., Morens D.M., Fauci A.S. The next influenza pandemic: can it be predicted?. JAMA 2007, 297:2025-2027.
28. Glezen W.P. Emerging infections: pandemic influenza. Epidem Year Revs 1996, 18:65-76.
29. Beveridge W.I.B. Influenza: the last great plague 1977, Heinemann, London.
30. Pyle G.F., Patterson K.D. Influenza diffusion in European history: patterns and paradigms. Eco Dis 1984, 2:175-184.
31. Ghendon Y. Introduction to pandemic influenza through history. Euro J Epidem 1994, 10:451-453.
32. Kilbourne E.D. Influenza pandemics in perspective. JAMA 1977, 237:1225-1228.
33. Payne A.M.M. The Asian influenza epidemic. JAMA 1958, 166:1009-1015.
34. Kung H.C., Jen K.F., Yuan W.C., Tien S.F., Chu C.M. Influenza in China in 1977. Recurrence of influenza A subtype H1N1. Bull WHO 1978, 56:913-918.
35. Kilbourne E.D. Influenza pandemics of the 20th century. Emerg Inf Dis 2006, 12:9-13.
36. Patterson K.D. Pandemic and epidemic influenza 1830-1848. Soc Sci Med 1985, 21:571-580.
37. Crosby A.W. Epidemic and peace 1918-1976, Greenwood Press, Westford, CT.
38. Pyle G.F. The diffusion of influenza: patterns and paradigms 1986, Rowan and Littlefield, New Jersey.
39. Claas E.C., Osterhaus A.D., Van Beer R., De Jong J.C., Rimmelswaan G.F., Senne D.A., et al. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet 1998, 351:472-477.
40. Yuen K.Y., Lhan P.K., Peiris M., Tsang D.N.C., Que T.L., Cheung P.T., et al. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 1998, 351:467-471.
41. The writing Committee of the WHO Consultation of human influenza A(H5). New Eng J Med 2005, 353(3):1374-1385.
42. Horimoto T., Kawaoka Y. Pandemic threat posed by avian influenza viruses. Clin Microbiol Revs 2001, 14:129-149.
43. Hayden F., Croisier A. Transmission of avian influenza viruses to and between humans. J Infect Dis 2005, 192:1311-1314.
44. http://www.who.int/car/disease/avian_influenza/country/cases_table_2011_03_07/en/index.html.
45. Zarocastas J. World Health Organisation declares A(H1N1) influenza pandemic. B.M.J 2009, 338. b2425.
46. Swine Influenza A (H1N1) Infection in Two Children - Southern California. CDC Morbidity & Mortality Weekly Reports 2009, 58(15):400-402.
47. Emergence of a novel swine-origin influenza A(H1N1) virus in humans. New Eng J Med 2009, 360(25):2605-2615. Novel Swine-Origin Influenza A (H1N1) Investigation Team.
48. The writing Committee of the WHO Consultation on clinical aspects of pandemic (H1N1) 2009 influenza. New Eng J Med 2010, 362(18):1708-1719.
49. WHO Weekly Epidemiological Record 2010, 85. 229-236.
50. Smith G.J.D., Vijaykriska D., Bahl J., Lycett S.J., Worobey M., Pybus D.G., et al. Origins and evolutionary genomics of the 2009 swine - origin H1N1 influenza A epidemic. Nature 2009, 459:1122-1125.
51. Update: influenza activity - United States. CDC Morbidity & Mortality Weekly Reports 2010, 59(14):423-430.
52. Magill T.P., Francis T. Antigenic differences in strains of human influenza virus. Proc Soc Exp Biol Med 1936, 19:463-466.
53. Dauer C.C., Serfling R.E. Mortality from influenza 1957-58 and 1959-60. Amer Rev Resp Dis 1961, 83:15-28.
54. Powers D.C., Belshe R.B. Vaccine-induced antibodies to heterologous influenza H1N1 viruses: effects of aging and " original antigenic sin" J Inf Dis 1994, 169:1125-1129.
55. Burnet F.M., Clarke E. Influenza 1942, MacMillan, London.
56. Masurel N. Serological characteristics of a " new" serotype of influenza A virus: the Hong Kong strain. Bull WHO 1969, 41:461-468.
57. Noble G.R. Epidemiology and clinical aspects of influenza. Basic and applied influenza research 1982, 11-50. CRC Press Boca Raton. A.S. Beare (Ed.).
58. Davenport F.M., Hennessy A.V., Francis T. Epidemiological and immunologic significance of age distribution of antibody to the antigenic variants of influenza virus. J Exp Med 1933, 98:641-665.
59. Taubenberger J.K., Morens D.M. Influenza: the once and future pandemic. Public health reports 2010, 125. Suppl 316-21.
60. Potter C.W. Influenza. Principle and practice of clinical virology 2004, 271-297. A.J. Zuckerman, J.E. Banatvala, J.R. Pattison, P.D. Griffiths, B.D. Schoob (Eds.).
61. Taubenberger J.K., Morens D. Pandemic influenza- including a risk assessment of H5N1. Rev Sci Tech 2009, 28:187-202.
62. Taubenberger J.K., Hultin J.V., Morens D.M. Discovery and characterization of the 1918 pandemic influenza virus in historical context. Antivir Ther 2007, 12:581-591.
63. Simonsen L., Clarke M.J., Williamson G., Stroup D.F., Arden N.H., Schonberger L.B. The impact of influenza epidemics on mortality: introducing a severity index. Amer J Pub Hlth 1997, 87:1944-1950.
64. Serum cross reactive antibody response to a novel influenza H1N1 virus after vaccination with seasonal influenza vaccine. MMWR-morbidity and Mortality Weekly Report 2009, 58(19):521-524. Centres for disease control and prevention.
65. Kilbourne E.D., Laver W.G., Schulman J.L., Webster R.G. Antiviral activity of antiserum specific for an influenza virus neuraminidase. J Virol 1968, 2:281-288.
66. Murphy B.R., Kasel J.A., Chanock R.M. Association of serum anti-neuraminidase antibody with resistance to influenza in man. New Eng J Med 1972, 286:1329-1332.
67. Horimoto T., Kawaoka Y. Influenza: lessons from past pandemics, warnings from current incidents. Nat Rev Microbiol 2005, 3:591-594.